Press release
Global Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Market to Reach $3.33 Billion by 2029, Growing at 10.9% CAGR
Chlamydia Trachomatis CT And Neisseria Gonorrhoeae NG Testing Market
The escalating incidence of sexually transmitted infections (STIs), projected to propel the expansion of the testing market for chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG). These infections typify maladies triggered by the onslaught of bacteria, viruses, or parasites transmitted via sexual contact. The escalation can be attributed to inadequate comprehensive sexual education, amplified sexual activity, looming stigma, and hurdles. Testing for chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) is employed for the detection and control of these infections, facilitating early diagnosis, medical treatment, and thwarting further transmission. For instance, per the data released in July 2023 by the World Health Organization, Switzerland, a global intergovernmental entity, everyday over 1 million sexually transmitted infections (STIs) are identified around the world, amassing an annual estimated count of 374 million new infections across 1 of 4 remediable STIs. Consequently, due to the escalating count of STIs, the CTNG testing market is experiencing growth.
Get Your Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/chlamydia-trachomatis-ct-and-neisseria-gonorrhoeae-ng-testing-global-market-report
What Is the projected market size and growth rate for the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market?
Over the recent years, there has been an accelerated expansion in the market size for chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing. The anticipated growth is from $1.98 billion in 2024 to a staggering $2.2 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.1%. Factors such as the rise in antibiotic resistance, increased consciousness through campaigns and education, and alterations in policies have contributed largely to the growth experienced during the historical period.
A swift expansion is anticipated in the market size of chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing in the forthcoming years, escalating to $3.33 billion by the end of 2029, exhibiting a compound annual growth rate (CAGR) of 10.9%. Telemedicine, telehealth initiatives, personalized medical treatment methods, broadened point-of-care testing, and population health management strategies are the key factors contributing to this growth during the forecast period. The forecast period is also expected to witness the growth of rapid point-of-care testing, individualized testing procedures, multi-disease testing platforms, and community-focused testing and outreach initiatives.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14667&type=smp
What are the emerging trends shaping the future of the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market?
Leading businesses in the CT and NG testing industry are concentrating on creating cutting-edge test solutions, such as the BD COR MX/PX System, a high-capacity molecular diagnostic platform for infectious diseases, with the aim of providing precise, effective, and scalable test methods in response to the growing prevalence of sexually transmitted infections. The BD COR MX/PX System is an advanced lab device or system engineered to promptly and efficiently assess a large quantity of samples for potential infectious agents. For example, in May 2022, Becton dic*kinson and Company, a medical device company located in the United States, introduced its fully automated, high-capacity molecular diagnostics platform for infectious diseases, namely the BD COR MX/PX System. This platform is designed to optimize the workflow in large labs that conduct a high volume of infectious disease tests, including CT and NG testing. Functioning with robotics and advanced software algorithms, it automates the entire procedure from sample reception to result delivery, which could significantly enhance efficiency and potentially shorten result waiting times. Additionally, it offers high throughput capability, dual DNA target analysis, and a modifiable and scalable structure.
What major market segments define the scope and growth of the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market?
The chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing market covered in this report is segmented -
1) By Test Type: Laboratory, Point Of Care Testing
2) By Product: Assays And Kits, Instruments Or Analyzers
3) By Technology: Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction, Immunodiagnostics, Other Technologies
4) By End User: Diagnostic Laboratories, Hospitals And Clinics, Other End Users
Subsegments:
1) By Laboratory: Nucleic Acid Amplification Tests (NAAT), Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence Assay (IFA), Culture Tests, Direct Fluorescent Antibody (DFA) Tests
2) By Point Of Care Testing: Rapid Diagnostic Tests (RDT), Lateral Flow Assays, Immunochromatographic Tests, Self-Testing Kits, Loop-Mediated Isothermal Amplification (LAMP), Microfluidics-Based Tests
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14667
Which region dominates the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market?
North America was the largest region in the chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing market in 2024. The regions covered in the chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which key market leaders are driving the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing industry growth?
Major companies operating in the chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton dic*kinson and Company, Grifols SA, Hologic Inc., PerkinElmer, bioMérieux, Sysmex Corporation, Bio-Rad Laboratories, QIAGEN, Quidel Corporation, DiaSorin, Cepheid, Seegene Inc., Meridian Bioscience Inc., Sekisui Diagnostics, J. Mitra & Co. Pvt. Ltd., Atlas Medical, Hardy Diagnostics, Molbio Diagnostics Pvt. Ltd., NG Biotech
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=14667&type=smp
What Is Covered In The Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Global Market Report?
• Market Size Forecast: Examine the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market for a structured understanding.
• Key Players Overview: Analyze major players in the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market.
• Segment Contributions: Evaluate how different segments drive overall growth in the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market.
• Industry Challenges: Identify potential risks and obstacles affecting the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market.
• Competitive Landscape: Review strategic developments in the chlamydia trachomatis (ct) and neisseria gonorrhoeae (ng) testing market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Market to Reach $3.33 Billion by 2029, Growing at 10.9% CAGR here
News-ID: 3908153 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Test
Key Differences Between Megger Test, Tan Delta Test, and Hi-Pot Test for Electri …
Electrical insulation plays a critical role in ensuring the safety and efficiency of electrical systems. To assess the condition of insulation and identify potential issues, three common tests are used: the Megger test, Tan Delta test, and Hi-Pot test. Each test serves a unique purpose and provides valuable insights into the state of electrical insulation. Here's a closer look at the differences between these three essential tests.
Megger Test: Insulation Resistance…
Vitamin Test Market: Global Vitamin Test Analysis and Forecast (2023-2029)Vitami …
12.04.2024: Vitamin Test Market Overview
The development of companion diagnostic tools and advances in personalised treatment are driving considerable growth and revolution in the oncology Vitamin Test market. In the era of precision medicine, where healthcare is increasingly customised for individual individuals based on their own genetic and molecular profiles, this market segment is essential. Ongoing innovation and development define the oncology Vitamin Test market. To find particular biomarkers, genetic mutations,…
CAGR 8.1% Homecare Pregnancy Test Kits Market By Type of Test (Urine Test For H …
The Homecare Pregnancy Test Kits market report by Reports and Data provides an extensive overview of the vital elements of the Homecare Pregnancy Test Kits market and factors such as the drivers, restraints, latest trends, supervisory scenario, competitive landscape, technological advancements, and others. Further, it mentions the market shares associated with the market in terms of both value and volume along with the segmentation. Space-age industrial and digitalization tools are…
Home Safety Test Kits Market, Home Safety Test Kits Market Trends, Home Safety T …
“Home Safety Test Kits Market” 2020-2025 Research Report is a professional and in-depth study on the current state of the market. Global Home Safety Test Kits market containing a complete view of the market size, business share, profit estimates, SWOT analysis and the regional landscape of the Industry. The report explains key challenges and future development prospects of the market. The Global Home Safety Test Kits analysis is provided for…
Test Data Management (TDM) Market - test data profiling, test data planning, tes …
The report categorizes the global Test Data Management (TDM) market by top players/brands, region, type, end user, market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
This report studies the global market size of Test Data Management (TDM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption…
Hearing Screening and Diagnostic Devices Market Demands with Major Tests: pure T …
New Market Research Reports Title "Hearing Screening And Diagnostic Devices Market 2018" Has Been Added to Crystal Market Research Report database.
Hearing Screening and Diagnostic Devices - Competitive Insights:
The leading players in the market are Gn Otometrics A/S, Otodynamics, Nashua Hearing Group, Siemens Healthineers, Natus Medical Incorporated, Interacoustics A/S, Neurosoft S.A, Accent Hearing Pty Ltd, MAICO Diagnostics GmbH and IntriCon Corporation. The major players in the market are profiled in detail…
